Progenity

Recent Finacing

Hybrid B

Recent Raise

$125M

Progenity develops molecular diagnostics for women's health (NIPT, carrier, pre-eclampsia, liquid biopsy) and GI diseases, plus microbiome/SIBO analytics and an oral protein-targeted GI therapeutic platform.